Mr. Asplen began his career in public service trying hundreds of cases both as a Senior Deputy District Attorney and a Federal Assistant US Attorney in the District of Columbia. Specializing in the prosecution of sex crimes and child abuse, Chris developed a nationally recognized expertise in DNA technology. Subsequently appointed Executive Director of the US Attorney General’s National Commission on the Future of DNA, Chris’s work managing the National Commission lead to receiving the U. S. Attorney General’s Award for Contributions to Public Safety.
After managing the Commission for four years, including speech writing for the US Attorney General, Congressional testimony and acting as Department of Justice spokesman for numerous media outlets including CNN, CBS News, Fox News, The New York Times, the Economist and Time Magazine, Chris moved to London as the Vice President of an International Governmental Affairs for his firm. From London he traveled to over 35 countries on six continents driving criminal justice and public policy promoting clients’ interests and working with US State Department resources to improve the business opportunities for US companies in their industry. He has met with the Ministers of Justice in several countries, testified before Parliaments in South Africa and The Philippines and has spoken at over 100 international conferences.
He has served as an adviser to the US State Department for the Global Initiative to Combat Nuclear Terrorism’s Nuclear Forensic Working Group and was appointed Executive Director of the Global Alliance for Rapid DNA Testing.
Mr. Asplen currently serves as the Executive Director of The National Criminal Justice Association (NCJA) . The Agency members of NCJA are responsible for the distribution and management of over $3 Billion in federal criminal justice focused funds. Those funds are applied across the entire breadth and scope of the criminal justice system: from law enforcement, DNA, prosecution, indigent defense, specialty court, corrections, community corrections and more.